...
机译:Akt激酶的靶向治疗在体外和体内体内抑制食管鳞状细胞癌生长
School of Basic Medical SciencesZhengzhou UniversityZhengzhou Henan China;
School of Basic Medical SciencesZhengzhou UniversityZhengzhou Henan China;
School of Basic Medical SciencesZhengzhou UniversityZhengzhou Henan China;
School of Basic Medical SciencesZhengzhou UniversityZhengzhou Henan China;
The Hormel Institute University of MinnesotaAustin Minnesota;
China‐US (Henan) Hormel Cancer InstituteZhengzhou Henan China;
China‐US (Henan) Hormel Cancer InstituteZhengzhou Henan China;
School of Basic Medical SciencesZhengzhou UniversityZhengzhou Henan China;
School of Basic Medical SciencesZhengzhou UniversityZhengzhou Henan China;
China‐US (Henan) Hormel Cancer InstituteZhengzhou Henan China;
Department of Biochemistry and Molecular BiologyShantou University Medical CollegeShantou Guangdong;
The Hormel Institute University of MinnesotaAustin Minnesota;
School of Basic Medical SciencesZhengzhou UniversityZhengzhou Henan China;
School of Basic Medical SciencesZhengzhou UniversityZhengzhou Henan China;
targeting AKT kinase activity; xanthohumol; AKT signaling pathway; esophageal squamous cell carcinoma;
机译:Akt激酶的靶向治疗在体外和体内体内抑制食管鳞状细胞癌生长
机译:Cirsiliol靶向酪氨酸激酶2,以抑制体外和体内食管鳞状细胞癌生长
机译:Purpurogallin是一种新型丝裂原激活的蛋白激酶激酶激酶1/2抑制剂,可在体外和体内抑制食管鳞状细胞癌生长
机译:小分子ONC201 / TIC10在体外和体内靶向化疗抗性结肠直肠癌干细胞
机译:SRC-ABL激酶抑制剂,SKI-606,体外和体内阻断乳腺癌侵袭,生长和转移
机译:AKT激酶的靶向治疗可在体内和体外抑制食管鳞状细胞癌的生长
机译:Akt激酶的靶向治疗抑制了体外和体内食管鳞状细胞癌生长